Boston Scientific invests in InnerDyne:
This article was originally published in Clinica
Executive Summary
Boston Scientific is evaluating the use of InnerDyne's biocompatible coatings with its implantable devices. The technology transfer involves an equity investment by Boston in InnerDyne, initial research support, future licence fees and royalty payments.